BACKGROUND: Many new candidate pharmaceuticals designed to improve recovery after stroke have been proposed recently, but there are still too few molecular imaging methods capable to assess their efficacy. A hallmark of the inflammatory reaction that follows focal cerebral ischemia is overexpression of the mitochondrial peripheral benzodiazepine receptor/18 kDa translocator protein (PBR/TSPO) in the monocytic lineage and astrocytes. This overexpression can be imaged with positron emission tomography (PET) using PBR/TSPO-selective radioligands such as [(18)F]DPA-714. PURPOSE: Here, we tested whether PET with [(18)F]DPA-714 would evidence the effect of minocycline, a broad spectrum antibiotic presently tested as neuroprotective agent after stroke, on the inflammatory reaction induced in an experimental model of stroke. PROCEDURES: Ten rats were subjected to a 2-h transient middle cerebral artery occlusion with reperfusion. Minocycline or saline was intravenously administrated 1 h after reperfusion and daily during the following 6 days. PET studies were performed using [(18)F]DPA-714 at 7 days after cerebral ischemia. RESULTS: In vivo PET imaging showed a significant decrease in [(18)F]DPA-714 uptake at 7 days after cerebral ischemia in rats treated with minocycline with respect to saline-treated animals. Minocycline treatment had no effect on the size of the infarcted area. CONCLUSION: Minocycline administered daily during 7 days after ischemia decreases [(18)F]DPA-714 binding, suggesting that the drug exerts an anti-inflammatory activity. [(18)F]DPA-714 PET is a useful biomarker to study novel anti-inflammatory strategies in experimental cerebral ischemia.
BACKGROUND: Many new candidate pharmaceuticals designed to improve recovery after stroke have been proposed recently, but there are still too few molecular imaging methods capable to assess their efficacy. A hallmark of the inflammatory reaction that follows focal cerebral ischemia is overexpression of the mitochondrial peripheral benzodiazepine receptor/18 kDa translocator protein (PBR/TSPO) in the monocytic lineage and astrocytes. This overexpression can be imaged with positron emission tomography (PET) using PBR/TSPO-selective radioligands such as [(18)F]DPA-714. PURPOSE: Here, we tested whether PET with [(18)F]DPA-714 would evidence the effect of minocycline, a broad spectrum antibiotic presently tested as neuroprotective agent after stroke, on the inflammatory reaction induced in an experimental model of stroke. PROCEDURES: Ten rats were subjected to a 2-h transient middle cerebral artery occlusion with reperfusion. Minocycline or saline was intravenously administrated 1 h after reperfusion and daily during the following 6 days. PET studies were performed using [(18)F]DPA-714 at 7 days after cerebral ischemia. RESULTS: In vivo PET imaging showed a significant decrease in [(18)F]DPA-714 uptake at 7 days after cerebral ischemia in rats treated with minocycline with respect to saline-treated animals. Minocycline treatment had no effect on the size of the infarcted area. CONCLUSION:Minocycline administered daily during 7 days after ischemia decreases [(18)F]DPA-714 binding, suggesting that the drug exerts an anti-inflammatory activity. [(18)F]DPA-714 PET is a useful biomarker to study novel anti-inflammatory strategies in experimental cerebral ischemia.
Authors: M Chen; V O Ona; M Li; R J Ferrante; K B Fink; S Zhu; J Bian; L Guo; L A Farrell; S M Hersch; W Hobbs; J P Vonsattel; J H Cha; R M Friedlander Journal: Nat Med Date: 2000-07 Impact factor: 53.440
Authors: Milla Koistinaho; Tarja M Malm; Mikko I Kettunen; Gundars Goldsteins; Sofie Starckx; Risto A Kauppinen; Ghislain Opdenakker; Jari Koistinaho Journal: J Cereb Blood Flow Metab Date: 2005-04 Impact factor: 6.200
Authors: V Wee Yong; Jennifer Wells; Fabrizio Giuliani; Steven Casha; Christopher Power; Luanne M Metz Journal: Lancet Neurol Date: 2004-12 Impact factor: 44.182
Authors: Petra Schweinhardt; Peter Fransson; Lars Olson; Christian Spenger; Jesper L R Andersson Journal: J Neurosci Methods Date: 2003-10-30 Impact factor: 2.390
Authors: Joan Montaner; Alex Rovira; Carlos A Molina; Juan F Arenillas; Marc Ribó; Pilar Chacón; Jasone Monasterio; José Alvarez-Sabín Journal: J Cereb Blood Flow Metab Date: 2003-12 Impact factor: 6.200
Authors: Yoshihiro Murata; Anna Rosell; Robert H Scannevin; Kenneth J Rhodes; Xiaoying Wang; Eng H Lo Journal: Stroke Date: 2008-10-16 Impact factor: 7.914
Authors: Santiago Rojas; Abraham Martín; Maria J Arranz; Deborah Pareto; Jesús Purroy; Esther Verdaguer; Jordi Llop; Vanessa Gómez; Joan D Gispert; Olga Millán; Angel Chamorro; Anna M Planas Journal: J Cereb Blood Flow Metab Date: 2007-04-25 Impact factor: 6.200
Authors: Elaine Setiawan; Alan A Wilson; Romina Mizrahi; Pablo M Rusjan; Laura Miler; Grazyna Rajkowska; Ivonne Suridjan; James L Kennedy; P Vivien Rekkas; Sylvain Houle; Jeffrey H Meyer Journal: JAMA Psychiatry Date: 2015-03 Impact factor: 21.596
Authors: Frederick M Lartey; G-One Ahn; Rehan Ali; Sahar Rosenblum; Zheng Miao; Natasha Arksey; Bin Shen; Marta Vilalta Colomer; Marjan Rafat; Hongguang Liu; Miguel A Alejandre-Alcazar; John W Chen; Theo Palmer; Frederick T Chin; Raphael Guzman; Billy W Loo; Edward Graves Journal: Mol Imaging Biol Date: 2014-12 Impact factor: 3.488
Authors: S Lavisse; K Inoue; C Jan; M A Peyronneau; F Petit; S Goutal; J Dauguet; M Guillermier; F Dollé; L Rbah-Vidal; N Van Camp; R Aron-Badin; P Remy; P Hantraye Journal: Eur J Nucl Med Mol Imaging Date: 2014-12-09 Impact factor: 9.236
Authors: I Suridjan; P M Rusjan; A N Voineskos; T Selvanathan; E Setiawan; A P Strafella; A A Wilson; J H Meyer; S Houle; R Mizrahi Journal: Neuroimage Date: 2013-09-21 Impact factor: 6.556